Latest / The Future of HIV Care
In HIV Care, the Nuances Matter
Myles Helfand and Laura Waters, M.D., FRCP, discuss recently published, clinically noteworthy findings from a trio of venerable HIV cohort studies. First, they review new data from the ATHENA study on non-AIDS events among so-called "HIV controllers." They then move on to recent findings from the START study regarding the link between ART initiation timing and cardiovascular disease risk. Finally, they explore new REPRIEVE data exploring the impact (or lack thereof) of statin use on non-cardiovascular events.
¶
Read (and share!) the full transcript…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.